We describe the development of a rapid colorimetric in situ hybridization technique utilizing oligonucleotide probes labeled with six biotin molecules at the 3' end to detect mdrl in mouse colon cancer cells growing in culture and in vivo. mRNA integrity was vedied by the use of a multibiotinylated poly d(T) oligonucleotide, and the specificity of the reaction was confirmed by use of labeled sense and anti-sense probes in serial cryostat sections and cultured cells. The multiple biotin label produced a strong signal after a short hy-* Correspondence to: TX 77030. bridization time. Avidin-alkaline phosphatase detection and the capillary technology used in the Microprobe Accelerated System allowed completion of the procedure in less than 5 hr. Excellent correlations with the MDR phenotype of the cells, Northern blot analysis, and immunohistochemistry recommend this procedure for identifying cells that express the MDR phenotype in culture and in vivo. (1 Hisrochem   Cyrochem 41:499-506, 1993) KEY WORDS: Colorimetric assay; In situ hybridization; mRNA.
Introduction
The resistance of tumor cells to one anti-neoplastic drug is frequently associated with cross-resistance to others. The resulting multidrug resistance (MDR) phenotype, a major limiting factor in the treatment of cancer (1-3), is often associated with amplification of the gene mdrl and overexpression of its product, an Mr 170,000 P-glycoprotein (3-5). This P-glycoprotein is a transmembrane transport protein that mediates the efflux of naturally occurring toxic products through an active transport mechanism (4-8). It is expressed in cells of the proximal kidney tubules, the luminal surface of the colon mucosa, and the biliary canalicular surface of hepatocytes (9). Its expression in these excretory organs suggests that this P-glycoprotein plays a physiological role in cell clearance of extrinsic or intrinsic toxic products. Tumors originating from these tissues usually exhibit high levels of the P-glycoprotein or its mRNA (7-ll), indicating that the signal for its expression can be maintained during neoplastic transformation (12) . Until recently, the identification of cells expressing the MDR phenotype in culture or in vivo depended on the use of antibodies to P-glycoprotein and immunofluorescence or immunohistochemistry techniques (13-15) and labor-intensive radioactive in situ hybridization methodology. Many tumors that are resistant to chemotherapy express levels of P-glycoprotein that are barely detectable in most assays except in the polymerase chain reaction (PCR) assay and radioactive in situ hybridization (ISH) (15) . ISH serves as a better indicator of synthetic activity of cells, since mRNA transcription occurs in hours whereas the protein synthesis can take days. ISH in conjunction with immunohistochemistry provides valuable information in determining the exact source of a protein, such as a growth factor, in a given tissue.
This report focuses on the development of a procedure for a non-radioactive ISH that can be used with cultured cells as well as frozen tissue sections and can be completed in less than 5 hr. This procedure is a modification of the ISH procedure developed by Brigati and co-workers for DNA (16), using specific oligonucleotides labeled with six biotin molecules at the 3' end and an avidin-alkaline phosphatase detection system (17). Two mdrlspecific oligonucleotide (anti-sense) probes produced strong reactions and were tested on a drugsensitive murine CT-26 colon carcinoma and its MDR variant growing in culture or in syngeneic Balbk mice. The results clearly show that ISH with biotinylated oligonucleotide probes is a rapid, accurate, and advantageous procedure for studying the MDR phenotype of tumor cells.
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able from Fisher Scientific (Fair Lawn, NJ). The hybridization cocktail was purchased from Research Genetics (Huntsville, AL).
Materials and Methods

Oligonucleotide Probes
Two murine mdrl-specific anti-sense oligonucleotide probes were designed, Mice based on the previously published cDNA sequence (18), and were designated as M1 and M2, MI, a single-stranded oligonucleotide whose sequence is 5'CTG'CCT'AAT'CWGTG'TAT'CWTCT 3' (42% GC content), is in the anti-sense orientation and is derived from translated sequences at position 420-444 of murine mdrl(l8). The sequence of the corresponding control sense M1 oligonucleotide is 5' AGA'CAG'ATA'CAC'AAGATT'AGG'CAG 3' .
M2, a single-stranded oligonucleotide whose sequence is 5' GAT'GGT'TCT' GAT'GTC'TTGTCC'G 3' (50% GC content), is in the anti-sense orientation and is derived from position 1359-1380 of the murine mdrl gene. A biotinylated poly d(T)3o single-stranded oligonucleotide was used to verdy the integrity of mRNA in each sample (19) . The specificity of each oligonucleotide sequence was initially determined by a GenEMBL database search using the Genetics Computer Group sequence analysis software package (GCG Madison, WI) based on the FastA algorithm (20) . All oligonucleotide sequences showed 100% homology with the target mdrl sequence and minimal homology with nonspecific mammalian gene sequences. The specificity of the oligonucleotide sequence was also confirmed by Northern blot analysis. All oligonucleotide probes, hyperbiotinylated at the 3' end (i.e., six biotin groups attached at the 3' end), were commercially synthesized using phosphoramidite chemistry (Research Genetics; Huntsville, AL). The probes were received in the lyophilized form and were reconstituted to a stock concentration of 1 vg/vl with TE buffer (10 mM Xis base, 1 mM EDTA, pH 7.5). The working dilution was obtained after titration of the probe with a known positive tissue or cells. In the case of poly d(T)30, the working dilution was a 1:2000 dilution of the stock. In the case of M1 and M2 the stock solution was diluted 1:400.
mRNA Analyses
Total cellular RNA was extracted from i07-108 tumor cells growing in culture, using a guanidinium thiocyanate-hot phenol method as previously described (21) . For Northern blot analyses, poly(A+) RNA was prepared by oligo (dT)-cellulose chromatography, fractionated on 1% denaturing formaldehyde-agarose gels, electrouansferred at 0.6 A to GeneScreen nylon membrane (DuPont; Boston, MA), and w cross-linked with 120,000 vJ/cm2 with a W Stratalinker 1800 (Stratagene; La Jolla, CA). Hybridizations were performed as described (22) . Filters were washed two or three times at 60-65°C with 30 mM NaCI-3 mM sodium citrate (pH 7.2)-0.1% NaDodS04. The DNA probes used were (a) a 4 . 3~~ EcoRl restriction endonuclease cDNA fragment from the plasmid pcDRK corresponding to the full-length mouse mdrl cDNA (18) and (b) a 1.3 KB PJ~I gene fragment corresponding to rat glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) (23) . Each DNA fragment was purified by agarose gel electrophoresis, recovered using Gene Clean (BIO 101; La Jolla, CA), and radiolabeled by the random primer technique using [ a-32P]-deoxyribonucleotide triphosphates (24) . mRNA expression was quantified on an LKB Ultrascan XL laser densitometer (Pharmacia LKB Biotechnology; Uppsala, Sweden) by averaging three separate measurements in the linear range of the film of the left, middle, and right areas of each mdrl transcript band, as well as control GAPDH transcripts (22) . Each sample measurement was calculated as the ratio of the average areas of the 4.3-KB mdrl transcript and the 1.3 KB GAPDH transcript.
Reagents
The Probe Wash, alkaline phosphatase enhancer, Ultraprobe alkaline phosphatase kit. aqueous hematoxylin, chromogen, and crystal mount were manufactured by Biomeda (Foster City, CA) and are commercially avail-Male Balblc mice were purchased from the Animal Production Area, NCI-Frederick Cancer Research Facility (Frederick, MD). The mice were maintained in a laminar flow cabinet under specific pathogen-free conditions and were used for experiments when they were 8 weeks old. Animals were maintained in facilities approved by the American Association for Accreditation of Laboratory Animal Care and in accordance with current regulations and standards of the United States Department of Agriculture, Department of Health and Human Services, and National Institutes of Health.
Tumor Cell Lines
The CT-26 colon carcinoma was induced in a Balblc mouse by methylcholentherene (25) . CT-26 cells are highly metastatic to the liver and lungs and have been used in many chemotherapy studies (26) . The cells were cultured in vitro with increasing concentrations of doxorubicin. After 8 weeks of continuous culture, a variant line resistant to 1 pg/ml of doxorubicin was isolated and designated CT-26 RSOO. These cells were maintained in medium containing 1 pg/ml doxorubicin.
Cell lines were maintained in Eagle's minimum essential medium (M. A. Bioproducts; Walkersville, MD) supplemented with 10% fetal bovine serum (FBS), sodium pyruvate, non-essential amino acids, L-glutamine, and twofold vitamin solution (Gibco; Grand Island, NY). The cell lines were free of Mycopfmma, reovirus Type 3, pneumonia virus of mice, mouse adenovirus, murine hepatitis virus, lymphocyte choriomeningitis virus, ectromelia virus, and lactic dehydrogenase virus (tested by Microbiological Associates; Bethesda, MD). Cultured cells were plated on ProbeOn glass slides for ISH as described below.
Production of Subcutaneous Tumors
Tumor cells were harvested from subconfluent cultures by a 3-min treatment with 0.25% trypsin and 0.02% EDTA. Trypsinization was stopped with medium containing 10% FBS, and cells were washed once in serumfree medium and re-suspended in Hanks' balanced salt solution (HBSS) for injection. Only single-cell suspensions with greater than 90% viability (tested by trypan blue exclusion) were used for in vivo injections.
To produce sc tumors, 2.5 x lo4 viable cells in 0.05 ml HBSS were injected with a 27-gauge needle into the sc tissue of the lateral flank. The mice were monitored daily. When tumors reached 10-12 mm in diameter, the mice were sacrificed, the tumors resected, and samples were prepared as described below.
Preparation of Samples for In Situ Hybridization
Tissue Culture Cells. The ProbeOn Plus slides were dry-sterilized in a 2OO' C oven for 2 hr, cooled, and placed in rectangular tissue culture dishes. The slides were seeded with tissue culture cells and incubated overnight under optimal tissue culture conditions. Slides with 75-85 % confluent cells were used in the assay. The cells were fixed with 4% paraformaldehyde in PBS for 30 min, rinsed with 50 mM glycine in Tris buffer (PH 7.6) for 3 min, treated with 1% Triton, rinsed with Tris buffer, and then treated with 0.2 N HCI for 20 min. The samples were rinsed with Tris buffer and then dehydrated in a graded series (70%, 80%, 95%, and 100%) of ethanol, followed by chloroform and 100% ethanol for 10 min each. The samples were acetylated (0.25% acetic anhydride in 0.1 M triethanolamine) for 10 min and hybridized as described below. (Samples were fixed and Frozen Tissues. At necropsy the tumor tissue was cut in half, and one half was processed for paraffin embedding and served as morphology control. The other half was cut into 5-mm pieces, placed in OCT compound (Miles Laboratories; Elkhart, IN) in 1-inch aluminum caps, and snap-frozen in liquid nitrogen. Sections (8-10 pm) were cut in an IEC Minotome cryostat (purchased from Fisher Scientific; Houston, IX) and picked up on silanetreated ProbeOn slides and air-dried for 30 min. The slides were placed in pairs in the Microprobe slide holder, fixed with 4% paraformaldehyde in %is buffer for 30 min, and treated in the same manner as tissue culture cells. The tumor samples were hybridized as described below.
In Sit# Hy bridzaton ISH was carried out using the Microprobe Manual Staining System (Fisher Scientific; Pittsburgh, PA), originally designed by one of us (DJB), consisting of an incubator that allows the pre-setting of three temperatures in the range of 30-100"C, a slide holder that holds 10 pairs of ProbeOn slides vertically, and a staining station for reagents and buffer washes (27).
Acetylated slides were rinsed with Tris buffer three times for 30 sec each time. Hybridization of the probe was carried out at 40'C for 40 min and the samples were then washed with Probe Wash three times for 3 min at 52'C. The samples were rinsed with alkaline phosphatase enhancer for 30 sec, incubated with alkaline phosphatase-labeled avidin for 30 min at 40'C, rinsed in 50 mM Tris buffer (pH 7.6). and incubated with the chromogen substrate for 20 min at 40'C. Additional incubation with fresh chromogen substrate was done if it was necessary to enhance a weak reaction. The samples were rinsed with Tris buffer and counterstained with aqueous hematoxylin, covered with Crystal Mount, heat-dried, and examined. The samples were mounted with Permount before photography.
Hybridization of the samples with a biotinylated poly d(T)30 probe was always used to confirm the compatibility of the sample preparation with the procedure. To check the specificity of the hybridization signal, the following controls were used (a) FWAse pre-treatment of sections, which digests all mRNA in the tissue, and (b) substituting a biotin-labeled sense probe for the anti-sense probe. No signal was obtained after either of these treatments. Control for endogenous alkaline phosphatase included treatment of the samples in the absence of the biotinylated probe and use of chromogen alone. For consistent results, it is advisable to avoid contamination of solutions, equipment, or tissue sections with ribonuclease. Water that has been treated with diethyl pyrocarbonate (DEPC) (Sigma; St Louis, MO) should be used as a diluent in the preparation of all solutions. Where possible, immunohistochemistry and ISH were performed on serial sections.
Antibodies
Mouse monoclonal antibody to P-glycoprotein, C219, was purchased from Centocor (Malvern, PA). Hybridoma cells producing monoclonal rat F4/80, an antibody that binds to a 160-KD plasma membrane glycoprotein present on mouse mononuclear phagocytes (28) . were the gift of Dr. David Hume (University of Queensland; Queensland, Australia). Gold-conjugated goat anti-mouse antibody, gold-conjugated goat anti-rat antibody, and Silver Intense were purchased from Amersham (Arlington Heights, IL).
Immunohistochemistry
Frozen sections were mounted on positively charged slides (Plus Slides; Fisher Scientific), air-dried for 30 min, fived in a 1:1 mixture of acetone:chloroform (previously stored at -20°C) for 5 min at room temperature, rinsed briefly with acetone, and transferred to PBS. The slides were placed in a humidified chamber and incubated with PBS containing 1% normal goat serum for 20 min and then 1% bovine serum albumin for 20 min, followed by appropriate dilutions of the primary antibody, and then incubated overnight at 4%. The slides were washed with PBS and incubated further with a 1:30 dilution of the corresponding gold-conjugated antibody for 1 hr at room temperature. The slides were washed with PBS, fixed with 2% glutaraldehyde in PBS for 10 min, and washed extensively with distilled water. The sections were treated with freshly prepared Silver Intense for 10 min. washed with distilled water, and examined either by brightfield microscopy or by epipolarization microscopy. Counterstaining with hematoxylin was sometimes done on duplicate slides, but only to emphasize the difference in intensity of reaction between the high and low expressors of the P-glycoprotein.
Results
In Situ Hybridization in Tissue Culture Cells
Alkaline phosphatase staining was observed in CT-26 R500 cells hybridized with both M1 and M2 oligonucleotide mdrl-specific probes (Figures la and Ib) . Both probes labeled the same types of cells, and the label was observed in both nucleus and cytoplasm. The cytoplasmic staining was observed as either a diffuse pink to red color or as dark red granules radiating from the perinuclear area. The M2 probe yielded a stronger signal than M1 but it sometimes masked the subtle differences in the staining reaction of the different cell types. Therefore, M1 was used as the probe to determine the synthetic activity of cells under various culture conditions. ISH with sense probe showed no label ( Figure IC) .
To illustrate the specificity and sensitivity of the probes, the reaction was carried out on parental drug-sensitive CT-26 cells and the drug-resistant variant CT-26 R500 line. The MDR cells were grown for 18 hr either in the absence or the presence of 1 pg/ml doxorubicin. As shown in Figure Id , the M1 probe produced only weak labeling of the nucleus of parental CT-26 cells. In contrast, the same probe yielded intense label in the nucleus and also in discrete red granules in the cytoplasm of the MDR CT-26 R5OO cells (Figure la) . The CT-26 R5OO cells cultured in medium with doxorubicin revealed more intense red granules in the cytoplasm than those cultured in drug-free medium ( Figure Id) . Similar results were obtained with the M2 probe, although the staining was more intense even with the parental cells. The CT-26 R5OO cells exhibited large red granules, although those released from doxorubicin for 18 hr showed slightly fewer cytoplasmic granules and less intense staining. The parental cells showed the least amount of staining.
In Situ Hybridization of Frozen Sections of Subcutaneous Tumors
To correlate the in vitro findings with tumors growing in vivo, ISH was performed on frozen sections of subcutaneous tumors. Tumors produced by the MDR line (CT-26 R5OO) appeared more cellular (smaller nuclei also) than the parental drug-sensitive (CT-26) line (Figures 2a and 2b) . In tissue sections, the intracellular staining pattern of the M1 probe differed from that seen in cultured cells. M1 staining in vivo was preferentially in the cytoplasm in the paraor perinuclear position. Both CT-26P and CT-26 R5OO cells showed strong cytoplasmic reactions (Figures 2a and 2b) . However, in the CT-26 R5OO cells a more polarized reaction was seen, mainly in the Golgi area, and the cytoplasmic staining was even more prominent. Cells negative for the probe, presumably host-infiltrating cells, were also found (Figure 2b) . ISH with the M2 probe showed staining that was both nuclear and cytoplasmic and a more intense reaction than did the M1 probe. The intense reaction often interfered with the counterstaining reaction. No staining was observed in the absence of the anti-sense probe (Figures 2c and 2d ) or with the sense probe. ISH with poly d(T)30 showed cytoplasmic staining (Figure 2e ).
Control Experiments
ISH of the cell lines with biotinylated poly d(T)3o showed staining of all cells (Figure lf) . ISH of the cell lines using the MI control sense oligonucleotide probe showed no staining in either the drug-sensitive or the drug-resistant cells. A reagent control hybridization reaction with no probes yielded no staining of either cell line. Cells were also hybridized either with the unlabeled probe or with various ratios of labeled to unlabeled probes. The experi- ments were performed at least three times and the slides were coded and then scored independently by three investigators. The independent scores showed that samples hybridized with unlabeled probe before application of the labeled probe yielded 40 staining and that samples hybridized with mixtures of labeled and unlabeled probes yielded reduced staining compared with samples hybridized with labeled probe only. rental cells. The CT-26 RSOO tumors also contained many macrophages interspersed among the tumor cells.
ImmanohistochemiJ~rY for Gh'cOprotein
To confirm the ISH data, we stained the subcutaneous CT-26 parental cells and the CT-26 RSOO tumors with the C219 antibody specific for the P-glycoprotein. More intense reactivity was found in the MDR line CT-26 R500, a finding that correlated directly with the results of the ISH technique (Figure 3 ).
Effect of Fixaton
CT-26 cells fixed in glutaraldehyde showed cytoplasmic signal with the M2 probe, whereas cells fixed in paraformaldehyde revealed nuclear and cytoplasmic signals. This discrepancy may be atuibutable to the extensive cross-linking observed in glutaraldehyde-fixed samples, thus rendering the nucleus inaccessible to the probe.
Histo logy
(3-26 parental cells growing subcutaneously exhibited elongated cells with large nuclei interspersed with macrophages, as determined by F4/80 staining. CT-26 RSOO cells growing subcutaneously were more cellular, with each cell having a smaller nucleus than the pa-
Northern BZot AnaZysis of mdrl
To confirm the ISH data, we determined the levels of the 4.3 KB mdrl-specific mRNA transcript by Northern blot analysis in the CT-26 parental (CT-26P) and CT-26 R500 cells growing in vitro and invivo as subcutaneous tumors (Figure 4, Lanes A-D) . Northem blot analysis demonsuated expression of the 4.3 KB mdrl-specific transcript in both the CT-26P and (3-26 RSOO cell types (Figure  4, Lanes A and B) . Densitometric quantitation of the mdrl expression level showed that CT-26 RSOO cells expressed steady-state levels of mdrl-specific mRNA approximately 20-fold higher than did CT-26P cells (Figure 4 ; compare Lane B with Lane A). Similar results were observed in the subcutaneous tumors resulting from these cell types. in which CT-26 RSOO tumors expressed approximately 20fold higher levels of the 4.3 KB mdrl-specific transcript than did CT-26P tumors (Figure 4 ; compare Lane D with Lane C). Similar results were obtained when the anti-sense ISH oligonucleotide was used as a hybridization probe (not shown). These results directly correlate with the ISH results. which showed more intense reactivity in the CT-26 RSOO than in the CT-26P cells.
Discussion
The present results demonstrate the advantages of a rapid nonradioactivc colorimetric ISH technique for detecting mRNA of mdrl in mouse colon cancer cells growing in vitro and in vivo. This ISH technique clearly revealed qualitative differences in mdrl mRNA bcrween parental CT-26 cells (drug sensirivc) and MDR (3-26 RSOO cells (drug resistant). The results obtained by the ISH technique correlated with those obtained by Northern blot analysis and by immunohistochemistry for P-glycoprotein.
Expression of the mdrl gene. whose product is P-glycoprotein, is associated with drug resistance (16). Mdrl mRNA levels determined in samples obtained from primary untreated human colon carcinomas were reported to be similar to levels observed in cells of a human epidermoid carcinoma cell line selected for intermediate resistance to colchicine. No gene amplification occurred in these variant cells, suggesting that the high levcls of mdrl mRNA in human colon cancer are the consequence of high transcriptional activity (1 1,12 ). Since the regulation of P-glycoprotein expression is complex and occurs at different levels, the ability to detect early changes in specific mRNA levels could contribute to the understanding of the mechanism of drug resistancc.
Our results indicate that ISH with specific multibiotinylated oligonucleotide probes for the mdrl gene can be used to detect changes in the levels of mRNA for mdrl in cells, such as was observed in drug-sensitive CT-26 cells and MDR CT-26 RSOO cells growing in the presence or absence of doxorubicin. The qualitative difference in the intensity and pattern of staining produced by the two probes may be due to differences in accessibility of the target mRNAs to the biotinylated oligonucleotides. The demonstration of labeled cytoplasmic granules in the MDR CT-26 RIO0 cells suggest increased cytoplasmic activity, which may represent increased transcription. Kiyama et al. (29) showed that when oligonucleotide probes are labeled directly with alkaline phosphatase the reaction product is often seen as punctate clusters in the cytoplasm. The clusters are presumed to be groups of polysomes. Both the M1 and M2 probes labeled the nuclei of parental and drug-resistant cells, suggesting that the specific mdrl mRNA is produced in both drug-sensitive and drug-resistant cells but that the release of mRNA into the cytoplasm (maturation) may occur after stimulation by doxorubicin. The M2 probe produced labeling in both nucleus and cytoplasm of CT-26P and CT-26 RSOO cells; however, cytoplasmic staining was more intense in the MDR cells.
The accelerated mRNA ISH technique described here offers several advantages. (a) The technique relies on specific oligonucleotide probes that are synthesized with six biotin molecules at the 3' end. Cook et al. (30) showed that oligomers labeled at or on the ends of the hybridizing sequence gave stronger signals than oligomers with internal labels. In addition, these authors also showed that multiple biotins (i.e., "tails") at either the 3' or I' terminus of the hybridizing sequences generated more signals than oligomers labeled with only one biotin, as is sometimes seen in commercial probes. (b) The technique can be completed in less than 5 hr. (c) This ISH technique can be used on tissue culture cells as well as on frozen tissues, thus allowing direct correlation with immunohistochemical results. (d) Unlike some commercial preparations in which a cocktail of labeled oligonucleotides is necessary to produce a signal, this technique enables us to examine hybridization of single probes to the target mRNA, thus increasing the specificity of the technique. (e) The use of non-radioactive probes preserves excellent cell morphology and allows determination of localization and subtle ddferences in staining intensity between the nucleus and the cytoplasm.
No technique, however, is devoid of some difficulties. We encountered some nonspecific binding of avidin-alkaline phosphatase to certain tissues, such as the bronchus of the lung and the liver parenchyma. Perhaps other labels such as digoxigenin can be adapted to the accelerated procedure to solve this problem (31). Attempts to block nonspecific binding of avidin included the following: (a) pre-treatment of tissue samples with an avidin wash (Vector Lab; Burlingame, CA); (b) levamasole; and (c) use of 1.5% fish gelatin (Norland Products; New Brunswick, NJ). Background labeling of some but not all tissues was suppressed by fish gelatin, but the other methods made no difference. More recently, a new source of the avidin-alkaline phosphatase reagent gave reduced background staining. It is possible that a variation in different batches of reagent may occur; therefore, it is wise to test several preparations.
In summary, we have developed a rapid colorimetric in situ mRNA hybridization technique utilizing DNA oligonucleotides synthesized with six biotin molecules at the 3' end to detect mdrl in mouse colon cancer cells. Excellent correlation with the MDR phenotype of the cells, Northern blot analysis data, and immunohistochemistry analysis all confirm that this technique is a useful tool for identifying cells that express the MDR phenotype in culture and in vivo.
